| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 51 |
| 1 | CICLESONIDE | 51 |
| 2 | GOSERELIN | 51 |
| 3 | METHOTREXATE SODIUM | 51 |
| 4 | PREDNISONE | 51 |
| 5 | ALENDRONATE SODIUM | 50 |
| 6 | BICALUTAMIDE | 50 |
| 7 | LANSOPRAZOLE | 50 |
| 8 | RAMIPRIL | 50 |
| 9 | CYCLOPHOSPHAMIDE | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDETATE CALCIUM DISODIUM | 29 | 0.7250 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 10 | 0.0855 |
| 2 | GOSERELIN | 51 | 0.0038 |
| 3 | CICLESONIDE | 51 | 0.0037 |
| 4 | BICALUTAMIDE | 50 | 0.0033 |
| 5 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 10 | 0.0024 |
| 6 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 7 | SODIUM BICARBONATE INJECTION, | 44 | 0.0019 |
| 8 | TRIMIPRAMINE | 2 | 0.0018 |
| 9 | ERGOCALCIFEROL | 46 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 55 |
| 1 | Androgen Receptor Inhibitor [EPC] | 51 |
| 2 | Proton Pump Inhibitor [EPC] | 51 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 50 |
| 4 | Alkylating Drug [EPC] | 49 |
| 5 | Provitamin D2 Compound [EPC] | 46 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 45 |
| 7 | Calcium [EPC] | 39 |
| 8 | Vitamin B12 [EPC] | 29 |
| 9 | Vitamin C [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 27 | 0.0392 |
| 1 | Provitamin D2 Compound [EPC] | 46 | 0.0015 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Androgen Receptor Inhibitor [EPC] | 51 | 0.0007 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 50 | 0.0004 |
| 5 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Calcium [EPC] | 39 | 0.0003 |
| 7 | Alkylating Drug [EPC] | 49 | 0.0002 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 26 | 0.0001 |